Home
/
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
/
Financials
/
Quarterly
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$23.55M
Nov 2, 2017
Q2
2017
Jun 30, 2017
$20.07M
Aug 2, 2017
Q1
2017
Mar 31, 2017
$24.92M
May 5, 2017
Q3
2017
Sep 30, 2016
$25.12M
Nov 2, 2017
Q2
2017
Jun 30, 2016
$20.75M
Aug 2, 2017
Q1
2017
Mar 31, 2016
$19.13M
May 5, 2017
Q3
2016
Sep 30, 2015
$13.92M
Nov 4, 2016
Q2
2016
Jun 30, 2015
$24.94M
Aug 4, 2016
Q1
2016
Mar 31, 2015
$17.65M
May 5, 2016
Q3
2015
Sep 30, 2014
$20.62M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$11.43M
Aug 5, 2015
Q1
2015
Mar 31, 2014
$11.64M
May 5, 2015
Q3
2014
Sep 30, 2013
$7.42M
Nov 5, 2014
Q2
2014
Jun 30, 2013
$6.05M
Aug 5, 2014
Q1
2014
Mar 31, 2013
$5.58M
May 8, 2014
Q3
2013
Sep 30, 2012
$2.78M
Nov 12, 2013
Q2
2013
Jun 30, 2012
$7.29M
Aug 9, 2013
Q1
2013
Mar 31, 2012
$10.04M
May 10, 2013
Q3
2012
Sep 30, 2011
$10.52M
Nov 1, 2012
Q2
2012
Jun 30, 2011
$10.63M
Aug 7, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$38.44M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$39.77M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$37.15M
May 12, 2025
Q3
2025
Sep 30, 2024
$39.97M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$36.01M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$38.81M
May 12, 2025
Q3
2024
Sep 30, 2023
$55.69M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$47.57M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$38.90M
May 9, 2024
Q3
2023
Sep 30, 2022
$32.31M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$35.47M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$33.17M
May 4, 2023
Q3
2022
Sep 30, 2021
$34.89M
Nov 8, 2022
Q3
2021
Jun 30, 2021
$34.89M
Nov 5, 2021
Q2
2022
Jun 30, 2021
$30.61M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$29.00M
May 6, 2022
Q3
2021
Sep 30, 2020
$19.08M
Nov 5, 2021
Q3
2021
Jun 30, 2020
$19.08M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$17.08M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$15.60M
May 6, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($38.00M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($41.93M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($426.08M)
May 12, 2025
Q3
2025
Sep 30, 2024
($60.73M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($173.32M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($78.18M)
May 12, 2025
Q3
2024
Sep 30, 2023
($66.87M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($69.83M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($88.02M)
May 9, 2024
Q3
2023
Sep 30, 2022
($76.97M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($71.39M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($81.50M)
May 4, 2023
Q3
2022
Sep 30, 2021
$16.54M
Nov 8, 2022
Q2
2022
Jun 30, 2021
($41.00M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($87.44M)
May 6, 2022
Q3
2021
Sep 30, 2020
($23.71M)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($23.09M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
$1.26M
May 6, 2021
Q3
2020
Sep 30, 2019
($29.12M)
Nov 3, 2020
Q2
2020
Jun 30, 2019
($24.60M)
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($38.88M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($44.85M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($428.93M)
May 12, 2025
Q3
2025
Sep 30, 2024
($64.08M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($175.85M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($81.36M)
May 12, 2025
Q3
2024
Sep 30, 2023
($82.49M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($73.18M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($91.25M)
May 9, 2024
Q3
2023
Sep 30, 2022
($74.62M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($67.97M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($77.52M)
May 4, 2023
Q3
2022
Sep 30, 2021
($74.48M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($37.57M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($33.71M)
May 6, 2022
Q3
2021
Sep 30, 2020
($24.18M)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($23.52M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($32.71M)
May 6, 2021
Q3
2020
Sep 30, 2019
($28.11M)
Nov 3, 2020
Q2
2020
Jun 30, 2019
($24.38M)
Aug 6, 2020